303 related articles for article (PubMed ID: 24967908)
21. Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.
Espitia CM; Saldarriaga OA; Travi BL; Osorio EY; Hernandez A; Band M; Patel MJ; Medina AA; Cappello M; Pekosz A; Melby PC
BMC Immunol; 2014 Nov; 15():38. PubMed ID: 25424735
[TBL] [Abstract][Full Text] [Related]
22. The major concanavalin A-binding surface glycoprotein of Leishmania donovani chagasi promastigotes is involved in attachment to human macrophages.
Wilson ME; Hardin KK
J Immunol; 1988 Jul; 141(1):265-72. PubMed ID: 3379307
[TBL] [Abstract][Full Text] [Related]
23. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction.
Moore KJ; Labrecque S; Matlashewski G
J Immunol; 1993 May; 150(10):4457-65. PubMed ID: 8482844
[TBL] [Abstract][Full Text] [Related]
24. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
Paul J; Karmakar S; De T
Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
[TBL] [Abstract][Full Text] [Related]
25. STAT6/Arg1 promotes microglia/macrophage efferocytosis and inflammation resolution in stroke mice.
Cai W; Dai X; Chen J; Zhao J; Xu M; Zhang L; Yang B; Zhang W; Rocha M; Nakao T; Kofler J; Shi Y; Stetler RA; Hu X; Chen J
JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31619589
[TBL] [Abstract][Full Text] [Related]
26. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
27. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
28. Leptin induces the phagocytosis and protective immune response in Leishmania donovani infected THP-1 cell line and human PBMCs.
Dayakar A; Chandrasekaran S; Veronica J; Maurya R
Exp Parasitol; 2016 Jan; 160():54-9. PubMed ID: 26688099
[TBL] [Abstract][Full Text] [Related]
29. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
30. Toll-Like Receptor- and Protein Kinase R-Induced Type I Interferon Sustains Infection of
Dias BT; Goundry A; Vivarini AC; Costa TFR; Mottram JC; Lopes UG; Lima APCA
Front Immunol; 2022; 13():801182. PubMed ID: 35154115
[No Abstract] [Full Text] [Related]
31. Differential Induction of SOCS Isoforms by
Chandrakar P; Parmar N; Descoteaux A; Kar S
J Immunol; 2020 Feb; 204(3):596-610. PubMed ID: 31882519
[TBL] [Abstract][Full Text] [Related]
32. TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection.
Schleicher U; Paduch K; Debus A; Obermeyer S; König T; Kling JC; Ribechini E; Dudziak D; Mougiakakos D; Murray PJ; Ostuni R; Körner H; Bogdan C
Cell Rep; 2016 May; 15(5):1062-1075. PubMed ID: 27117406
[TBL] [Abstract][Full Text] [Related]
33. Leishmania donovani activates SREBP2 to modulate macrophage membrane cholesterol and mitochondrial oxidants for establishment of infection.
Mukherjee M; Basu Ball W; Das PK
Int J Biochem Cell Biol; 2014 Oct; 55():196-208. PubMed ID: 25218172
[TBL] [Abstract][Full Text] [Related]
34. Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis.
Suman SS; Amit A; Singh KP; Gupta P; Equbal A; Kumari A; Topno RK; Ravidas V; Pandey K; Bimal S; Das P; Ali V
Cytokine; 2018 Aug; 108():1-8. PubMed ID: 29554571
[TBL] [Abstract][Full Text] [Related]
35. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
36. Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis.
Mallick S; Halder S; Dutta A; Dey S; Paul K; Maiti S; Bandyopadhyay C; Saha B; Pal C
Int Immunopharmacol; 2013 Apr; 15(4):772-9. PubMed ID: 23499679
[TBL] [Abstract][Full Text] [Related]
37. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis.
Stäger S; Smith DF; Kaye PM
J Immunol; 2000 Dec; 165(12):7064-71. PubMed ID: 11120835
[TBL] [Abstract][Full Text] [Related]
38. Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression.
Edukulla R; Singh B; Jegga AG; Sontake V; Dillon SR; Madala SK
J Biol Chem; 2015 May; 290(21):13510-20. PubMed ID: 25847241
[TBL] [Abstract][Full Text] [Related]
39. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
[TBL] [Abstract][Full Text] [Related]
40. Immunomodulation of dual specificity phosphatase 4 during visceral leishmaniasis.
Parveen S; Chowdhury AR; Jawed JJ; Majumdar SB; Saha B; Majumdar S
Microbes Infect; 2018 Feb; 20(2):111-121. PubMed ID: 29133249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
